Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Src tyrosine-protein kinase (Src), also known as proto-oncogene c-Src, is a non-receptor tyrosine kinase encoded by the SRC gene in humans. It is the prototypical member of the Src family kinases (SFKs), which are involved in regulating various cellular processes including growth, differentiation, migration, survival, and cytoskeletal organization. Elevated or dysregulated activity of c-Src has been implicated in cancer progression due to enhanced cell proliferation/migration signals.
Inhibition of Src tyrosine kinase activity by binding to the ATP-binding site.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Src tyrosine-protein kinase (Src).